Showing results (91-100 of 437) with videos related to

Sort By:
Pageof 44
Arthritis and Rheumatism|April 12, 2011
Novel evidence-based colchicine dose-reduction algorithm to predict and prevent colchicine toxicity in the presence of cytochrome P450 3A4/P-glycoprotein inhibitorsRobert A Terkeltaub, Daniel E Furst, Jennifer L Digiacinto, et al.
Seminars in Arthritis and Rheumatism|August 15, 2015
A right ventricular diastolic impairment is common in systemic sclerosis and is associated with other target-organ damageChristophe Meune, Dinesh Khanna, Jamil Aboulhosn, et al.
The Journal of Rheumatology|August 16, 2015
Longterm Safety of Rituximab: Final Report of the Rheumatoid Arthritis Global Clinical Trial Program over 11 YearsRonald F van Vollenhoven, Roy M Fleischmann, Daniel E Furst, et al.
The Journal of Rheumatology|October 11, 2002
Longitudinal measurement of methotrexate liver concentrations does not correlate with liver damage, clinical efficacy, or toxicity during a 3.5 year double blind study in rheumatoid arthritisNihal H Fathi, Frank Mitros, John Hoffman, et al.
Current Rheumatology Reviews|August 3, 2010
Systemic Sclerosis-Associated Interstitial Lung Disease: Lessons from Clinical Trials, Outcome Measures, and Future Study DesignDinesh Khanna, James R Seibold, Athol Wells, et al.
Clinical Rheumatology|February 27, 2017
Misalignment between physicians and patient satisfaction with psoriatic arthritis disease controlDaniel E Furst, Melody Tran, Emma Sullivan, et al.
Seminars in Cutaneous Medicine and Surgery|July 27, 2017
Highlights of Skin Disease Education Foundation's 41st Annual Hawaii Dermatology Seminar™Kenneth B Gordon, Craig L Leonardi, Daniel E Furst, et al.
The Journal of Rheumatology|December 7, 2005
Scleroderma--developing measures of responseDaniel E Furst, Dinesh Khanna, Marco Mattucci-Cerinic, et al.
Rheumatology and Therapy|September 6, 2021
Biologic and Targeted Synthetic DMARD Utilization in the United States: Adelphi Real World Disease Specific Programme for Rheumatoid ArthritisElizabeth A Holdsworth, Bethany Donaghy, Kathleen M Fox, et al.
Rheumatology and Therapy|February 20, 2022
Post Hoc Analysis of Predictors of Clinical Response to Repository Corticotropin Injection in Persistently Active Rheumatoid ArthritisRoy Fleischmann, Kyle Hayes, Sung-Woo Ahn, et al.
Pageof 44